FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

Lithuania

Lithuania (Observer)

 

Contact: zivile.gudleviciene@nvi.lt

Website: https://www.nvi.lt/biobank/

 

 

Lithuania joined BBMRI-ERIC on 15th April 2020, and nominated the National cancer institute (NCI) as the Lithuanian National Biobank Node (BBMRI.lt; LBN). LBN is the umbrella organisation of biobanks in Lithuania that represents the interests of Lithuanian biobanks within BBMRI-ERIC network. LBN is also the primary contact point in Lithuania for all stakeholders in biobanking.

 

Under the leadership of National Cancer Institute (NCI), 6 institutions work together on the project “Human Biological Resource Center” to create a common visionary infrastructure, empower human resources, scientific expertise and stimulate biobaking activities in the country. LBN aims to create a harmonised, efficient and leading biobank infrastructure, an open access research platform, that boosts Lithuanian biomedical research, healthcare, and biomedical industry while fastering integration to the European Research Area.

 

Currenlty, national biobank gathers, maintains and processes mainly cancer related biological material, including tissue, blood, serum, plasma, cell, DNA and RNA and associated clinical, demographical data. Over 16 000 samples are cumulated and stored over recent years in biobank. This number will increase with extended inclusion of biological material from different participant segments: diseased, population-based and healthy volunteers.

 

The main areas Lithuanian Biobank Node will focus on :

  • Variability and extent of sample collections along with comprehensive data;
  • Ethically and legally protected data;
  • Harmonisation and sustainability of sample data and standard operating procedures across involved clinical, academic and research institutions;
  • Establishment of open access research platform which serves Lithuanian biomedical research, healthcare and industry.
  • Links with European and other international biobanking initiatives and networks such as BBMRI-ERIC.
  • Promotion of public awareness of biobanking potential in biomedical research, population health and personalised medicine.

ZIVILE GUDLEVICIENE


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept